Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 2
2007 2
2008 3
2009 2
2010 5
2011 2
2012 9
2013 8
2014 7
2015 13
2016 8
2017 11
2018 7
2019 11
2020 13
2021 10
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 32513905

101 results

Results by year

Filters applied: . Clear all
Page 1
Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
Savsani E, Shaw CM, Forsberg F, Wessner CE, Lyshchik A, O'Kane P, Liu JB, Balasubramanya R, Roth CG, Naringrekar H, Keith SW, Tan A, Anton K, Bradigan K, Civan J, Schultz S, Shamimi-Noori S, Hunt S, Soulen MC, Mattrey RF, Kono Y, Eisenbrey JR. Savsani E, et al. Radiology. 2023 Oct;309(1):e230727. doi: 10.1148/radiol.230727. Radiology. 2023. PMID: 37847138 Clinical Trial.
A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis.
Taiji R, Lin YM, Chintalapani G, Lin EY, Huang SY, Mahvash A, Avritscher R, Liu CA, Lee RC, Resende V, Nishiofuku H, Tanaka T, Kichikawa K, Klotz E, Gupta S, Odisio BC. Taiji R, et al. Eur Radiol Exp. 2023 Jan 30;7(1):4. doi: 10.1186/s41747-022-00315-8. Eur Radiol Exp. 2023. PMID: 36717474 Free PMC article.
Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: Impact of Embolic Density and Residual Tumor Perfusion on Tumor Recurrence and Survival.
Ruff C, Artzner C, Syha R, Grosse U, Hoffmann R, Bitzer M, Partovi S, Horger M, Nikolaou K, Grözinger G. Ruff C, et al. Cardiovasc Intervent Radiol. 2021 Sep;44(9):1403-1413. doi: 10.1007/s00270-021-02858-6. Epub 2021 May 21. Cardiovasc Intervent Radiol. 2021. PMID: 34021375 Free PMC article.
101 results